相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions
A. Vultaggio et al.
ALLERGY (2010)
Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta
Miranda M. C. van Beers et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Immunological mechanism underlying the immune response to recombinant human protein therapeutics
Melody Sauerborn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
M. K. de Vries et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Dealing with immunogenicity of biologicals: assessment and clinical relevance
Gerrit J. Wolbink et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Immunogenicity of Aggregates of Recombinant Human Growth Hormone in Mouse Models
Amber Haynes Fradkin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Principles, Approaches, and Challenges for Predicting Protein Aggregation Rates and Shelf Life
William F. Weiss et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
The immunogenicity of therapeutic proteins and the Fabry antibody standardization initiative
Huub Schellekens
CLINICAL THERAPEUTICS (2008)
Requirements for the natural killer cell-mediated induction of IgG1 and IgG2a expression in B lymphocytes
Ning Gao et al.
INTERNATIONAL IMMUNOLOGY (2008)
Immunogenicity of protein therapeutics
Anne S. De Groot et al.
TRENDS IN IMMUNOLOGY (2007)
Immunogenicity, efficacy and adverse events of adalimumab in RA patients
Niko K. Bender et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2005)
Immunologic mechanisms of EPO-associated pure red cell aplasia
H Schellekens
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Factors influencing the immunogenicity of therapeutic proteins
H Schellekens
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Development of a transgenic mouse model immune tolerant for human interferon beta
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2005)
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
H Schellekens
CLINICAL THERAPEUTICS (2002)
分享论文
